| Selective pressure-regulated retroinfusion of coronary veins as an alternative access of ischemic myocardium: implications for myocardial protection, myocardial gene transfer and angiogenesis. | |
| | |
MedLine Citation:
|
PMID: 11151777 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is renewed interest in the coronary venous system as an alternative access to ischemic myocardium. Selective pressure-regulated retroinfusion is a catheter-based approach which has been shown to increase the efficacy of retrograde oxygen delivery and drugs in experimental and clinical studies. Selective pressure-regulated retroinfusion may also target retrograde delivery of angiogenic growth factors and gene vectors to ischemic myocardium. |
| | |
Authors:
|
P Boekstegers; G von Degenfeld; W Giehrl; C Kupatt; W Franz; G Steinbeck |
Related Documents
:
|
430387 - The effect of carbon dioxide upon myocardial contractile performance, blood flow and ox... 6812937 - Coronary artery compliance in the dog. 15229387 - Effect of long-term angiotensin ii type i receptor antagonism on peripheral and coronar... 2058737 - Bradykinin increases myocardial contractility: relation to the gregg phenomenon. 4030197 - Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure. 17250947 - Protein synthesis inhibition as a potential strategy for metabolic down-regulation. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Zeitschrift für Kardiologie Volume: 89 Suppl 9 ISSN: 0300-5860 ISO Abbreviation: Z Kardiol Publication Date: 2000 |
Date Detail:
|
Created Date: 2001-01-09 Completed Date: 2001-04-12 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0360430 Medline TA: Z Kardiol Country: Germany |
Other Details:
|
Languages: eng Pagination: IX/109-12 Citation Subset: IM |
Affiliation:
|
Klinikum Grosshadern, Ludwig-Maximilians-Universität of Munich, 81366 Munich, Germany. boekstegers@med1.med.uni-muenchen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiogenesis Inducing Agents
/
administration & dosage* Animals Coronary Circulation Coronary Vessels* Electrocardiography Fibroblast Growth Factor 2 / administration & dosage Gene Expression Gene Transfer Techniques* Genes, Reporter / genetics Heart Catheterization Humans Infusions, Intravenous / methods* Myocardial Infarction / therapy Myocardial Ischemia / drug therapy, therapy* Pharmaceutical Preparations / administration & dosage* Pressure Shock, Cardiogenic / therapy Swine Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inducing Agents; 0/Pharmaceutical Preparations; 103107-01-3/Fibroblast Growth Factor 2 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Myocardial hibernation--adaptation to ischemia.
Next Document: Role of antibodies in transplant-associated cardiac allograft vasculopathy.